Literature DB >> 8216593

The injured motor cycle messenger.

D I Sweetnam1, F Morris, A Cope.   

Abstract

Injured motor cycle messengers make up a small but significant proportion of the young injured attending Central London accident and emergency (A&E) departments. The study confirms that the pattern of their injuries is similar to other injured urban motor cyclists, and discusses the background of the injured, in terms of experience and training, highlighting the frequency of injury and possible predisposing factors. A total of 116 injured motor cycle messengers attending two Central London A&E departments over a 10-month period were studied. Thirteen per cent sustained sufficiently serious injuries to necessitate admission, the rest were treated as out-patients for lesser injuries. The mean age was 23. Only 18% had received any formal training and 31% were in possession of a provisional driving license only. Fifty-eight per cent had been employed as a messenger for less than 3 months, yet two-thirds of them had sustained a previous injury whilst a messenger. The apparent absence of supervision of this potentially dangerous occupation is emphasized. In view of the repeated injuries sustained by many of these vulnerable young men, it is suggested that those responsible for their treatment might, in addition to their therapeutic role, give suitable guidance that might prevent re-attendance with further injuries.

Entities:  

Mesh:

Year:  1993        PMID: 8216593      PMCID: PMC1285987          DOI: 10.1136/emj.10.3.193

Source DB:  PubMed          Journal:  Arch Emerg Med        ISSN: 0264-4924


  2 in total

1.  Motorcycle messenger mania.

Authors:  A R Cope; P R Driscoll; D V Skinner; C A McLaughlan
Journal:  Br Med J (Clin Res Ed)       Date:  1987-12-12

2.  A study of reported injury accidents among novice motorcycle riders in a Scottish region.

Authors:  F Namdaran; R A Elton
Journal:  Accid Anal Prev       Date:  1988-04
  2 in total
  1 in total

1.  Work-related road accidents in France.

Authors:  B Charbotel; M Chiron; J L Martin; A Bergeret
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.